Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Daiichi Sankyo Holds Dialogue with Employees on Downsizing Plan
October 2, 2006
- Medtronic: Micro-Driver Stent System
October 2, 2006
- BUSINESS NEWS IN BRIEF
October 2, 2006
- MEDICAL DEVICE NEWS IN BRIEF
October 2, 2006
- SEMINAR Users' Complaints Are Gold Mines: Dr Tsuji of J&T Institute
October 2, 2006
- General Assembly of Med. Association-Operated Med. Facilities
October 2, 2006
- TOPICS GSK Opens Website on Blepharospasms,Hemifacial Spasms, Spasmodic Torticollis
October 2, 2006
- Med. Institutions Claiming Nicotine Dependence Management Fee Show Large Increase
October 2, 2006
- 200 Applications Received to Align Indications with Original Products
October 2, 2006
- Reducing Average Length of Hospital Stay Essential: Vice Minister
October 2, 2006
- One in Five People Are Aware of Dysuria Symptoms: Pfizer Survey
September 25, 2006
- Bio Japan 2..6
September 25, 2006
- Shionogi, Nichia Celebrate 30th Anniversary of Nichia Pharmaceutical
September 25, 2006
- IHEP Symposium on Clinical Trials
September 25, 2006
- ELD to Focus on Improving Access to New Drugs
September 25, 2006
- Crestor's Safety Confirmed in Japanese Patients: AstraZeneca, Shionogi
September 25, 2006
- NIBIO Opens 2nd Invitation to FY2006 Basic Research Grants
September 25, 2006
- REGULATORY NEWS IN BRIEF
September 25, 2006
- Roche Actively Seeking R&D Partnerships in Japan: Dr Noguchi
September 25, 2006
- MEXT, METI, Korosho to Cooperate to Promote Translational Research
September 25, 2006
ページ
Japan will overhaul its R&D tax credit regime in its FY2026 reform, introducing a new strategic category alongside existing frameworks.…
Strategic Talent Acquisition in the Japanese Life Sciences Sector: Your Market Intelligence Briefing
Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…